Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Caleres (CAL) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Caleres (CAL) over the last 17 years, with Q4 2025 value amounting to $34.0 million.

  • Caleres' Cash & Equivalents rose 82.53% to $34.0 million in Q4 2025 from the same period last year, while for Nov 2025 it was $34.0 million, marking a year-over-year increase of 82.53%. This contributed to the annual value of $29.6 million for FY2025, which is 3875.83% up from last year.
  • As of Q4 2025, Caleres' Cash & Equivalents stood at $34.0 million, which was up 82.53% from $191.5 million recorded in Q3 2025.
  • In the past 5 years, Caleres' Cash & Equivalents ranged from a high of $191.5 million in Q3 2025 and a low of $21.4 million during Q1 2024
  • For the 5-year period, Caleres' Cash & Equivalents averaged around $51.8 million, with its median value being $34.0 million (2023).
  • Its Cash & Equivalents has fluctuated over the past 5 years, first plummeted by 6589.27% in 2022, then surged by 27001.53% in 2025.
  • Caleres' Cash & Equivalents (Quarter) stood at $74.8 million in 2021, then plummeted by 56.17% to $32.8 million in 2022, then rose by 3.84% to $34.0 million in 2023, then decreased by 1.02% to $33.7 million in 2024, then increased by 0.83% to $34.0 million in 2025.
  • Its Cash & Equivalents was $34.0 million in Q4 2025, compared to $191.5 million in Q3 2025 and $33.1 million in Q2 2025.